| Patent application number | Description | Published |
|---|
| 20080249108 | Chemical Compounds - The invention relates to methods for the treatment of medical conditions comprising administering an effective amount of a compound of formula (I): | 10-09-2008 |
| 20080262041 | Beta-Lactams for Treatment of Cns Disorders - The present invention relates to novel compounds of formula (I): | 10-23-2008 |
| 20080269208 | Pyridine Derivatives and Their Use in the Treatment of Psychotic Disorders - There are provided according to the invention novel compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof: | 10-30-2008 |
| 20080280969 | Novel Compounds - The invention provides a compound of formula (I), pharmaceutical compositions thereof, and methods of treatment using the same. | 11-13-2008 |
| 20080293753 | Novel Compounds - The invention relates to quaternary α-aminocarboxyamide derivatives of formula (I), wherein R | 11-27-2008 |
| 20080306122 | Novel Compounds - Compounds of formula (I) wherein the variables are defined herein, pharmaceutical compositions thereof and methods for treatment using the same. | 12-11-2008 |
| 20090022670 | NOVEL COMPOUNDS - Disclosed are imidazo[1,2-a]pyridin-2-ylmethyl substituted piperidine derivatives of formula (I) | 01-22-2009 |
| 20090192194 | Cyclic Amine Derivatives, Processes For Their Preparation, And Pharmaceutical Compositions Containing Them - A compound of formula (I) | 07-30-2009 |
| 20090286836 | Novel Compounds - The invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R is C | 11-19-2009 |
| 20090318530 | PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS - The present invention relates to pharmaceutical compositions comprising an NK1 receptor antagonist and a sodium channel blocker compound of formula (I) | 12-24-2009 |
| 20090326032 | PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS - The present invention relates to pharmaceutical compositions comprising an NK1 receptor antagonist and a sodium channel blocker compound of formula (I) | 12-31-2009 |
| 20100081667 | Chemical Compounds - The present invention provides a method for the treatment of emesis in a mammal being treated with an opiod analgesic | 04-01-2010 |
| 20100105688 | PHARMACEUTICAL COMPOSITIONS COMPRISING 3,5-DIAMINO-6-(2,3-DICHLOPHENYL)-1,2,4-TRIAZINE OR R(-)-2,4-DIAMINO-5-(2,3-DICHLOROPHENYL)-6-FLUOROMETHYL PYRIMIDINE AND AN NK1 - The present invention relates to pharmaceutical compositions comprising an NK1 receptor antagonist and a sodium channel blocker, wherein at least one of them is at subtherapeutic dose, as a combined preparation for simultaneous or sequential administration, and to the use of such compositions in the treatment of certain disorders, including epilepsy, mood disorders and pain. | 04-29-2010 |
| 20100105754 | 5-(4PHENYL)PROLINAMIDE FOR TREATMENT OF EPILEPSY - The invention provides a compound of formula (I), a solvate, a salt or prodrug thereof, | 04-29-2010 |
| 20100113521 | PHARMACEUTICAL COMPOSITIONS COMPRISING 2-METHOXY-5-(5-TRIFLUOROMETHYL-TETRAZOL-1-YL-BENZYL)-(2S-PHENYLPIPERIDIN-- 3S-YL-) - The present invention relates to pharmaceutical compositions comprising the NK1 receptor antagonist [2-Methoxy-5-(5-trifluoromethyl-tetrazol-1-yl)-benzyl]-(2S-phenyl-piperidin-3S-yl)-amine, or a pharmaceutically acceptable salt or solvate thereof, and a sodium channel blocker, as a combined preparation for simultaneous or sequential administration and to the use of such compositions in the treatment of certain disorders, including epilepsy, mood disorders and pain. | 05-06-2010 |
| 20100130583 | PROLINAMIDE DERIVATIVES AS MODULATORS OF VOLTAGE-GATED SODIUM CHANNELS - The invention relates to quaternary α-aminocarboxyamide derivatives of formula (I) and their pharmaceutically salts or solvates | 05-27-2010 |
| 20100144760 | NOVEL COMPOUNDS - Disclosed are N-{[(1R,4S,6R)-3-(2-pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and their use as pharmaceuticals. | 06-10-2010 |
| 20100152175 | Pyridine Derivatives and Their Use in The Treatment of Psychotic Disorders - There are provided according to the invention novel compounds of formula (I) or a pharmaceutically acceptable salt thereof: | 06-17-2010 |
| 20100152446 | Piperidine Derivatives - The present invention relates to piperidine derivatives of formula (I) | 06-17-2010 |
| 20100160344 | NOVEL COMPOUNDS - This invention relates to imidazopyrimidine substituted piperidine derivatives and their use as pharmaceuticals. | 06-24-2010 |
| 20100160345 | NOVEL COMPOUNDS - This invention relates to imidazopyrazine substituted piperidine derivatives and their use as pharmaceuticals. | 06-24-2010 |
| 20100168131 | NOVEL COMPOUNDS - Disclosed are N-{[(1S,4S,6S)-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and their use as pharmaceuticals. | 07-01-2010 |
| 20100210667 | IMIDAZO [1, 2-C] PYRIMIDIN-2-YLMETHYLPIPERIDINES AS OREXIN RECEPTOR ANTAGONISTS - Disclosed are imidazo[1,2-c]pyrimidin-2-ylmethyl substituted piperidine derivatives having the formula: | 08-19-2010 |
| 20100267730 | NOVEL COMPOUNDS - This invention relates to imidazopyridazine substituted piperidine derivatives and their use as pharmaceuticals. | 10-21-2010 |
| 20100324022 | NOVEL COMPOUNDS - Compounds of formula (I), pharmaceutical compositions thereof, and methods for treatment using the same. | 12-23-2010 |
| 20110053922 | Spiro (Piperidine-4,2'-Pyrrolidine)-1-(3,5-Trifluoromethyl Phenyl) Methylcarboxamides As NK1 Tachikynin Receptor Antagonists - Compounds of formula (I) or a pharmaceutically acceptable salt thereof | 03-03-2011 |
| 20110053979 | PYRIDINE DERIVATIVES USED TO TREAT OREXIN RELATED DISORDERS - This invention relates to pyridinamine methyl substituted piperidinyl derivatives I and their use as pharmaceuticals. | 03-03-2011 |
| 20110060015 | 5-[5-[2-(3,5-BIS(Trifluoromethyl)Phenyl)-2-MethylpropanoMethylpropanoylmet- hylamino]-4-(4-Fluoro-2-Methylphenyl)]-2-Pyridinyl-2-Alkyl-Prolinamide As NK1 Receptor Antagonists - The invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R is C | 03-10-2011 |
| 20110098335 | NOVEL COMPOUNDS - The invention provides a compound of formula (I), a solvate, a salt or prodrug thereof, | 04-28-2011 |
